Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β 2 -Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care

ConclusionsThe results suggest that FP/FORM was associated with an overall lower adverse outcome rate than the licensed comparators.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research